首页 > 最新文献

Journal of Pathology and Translational Medicine最新文献

英文 中文
Liquid-based cytology features of pancreatic acinar cell carcinoma: comparison with other non-ductal neoplasms of the pancreas. 胰腺尖细胞癌的液基细胞学特征:与胰腺其他非导性肿瘤的比较。
IF 1.7 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-09 DOI: 10.4132/jptm.2024.06.25
Minji Kwon, Seung-Mo Hong, Kyoungbun Lee, Haeryoung Kim

Background: Acinar cell carcinoma (ACC) is a rare malignant epithelial neoplasm, which shares many cytomorphological features with other non-ductal pancreatic neoplasms such as pancreatic neuroendocrine neoplasm (PanNEN) and solid-pseudopapillary neoplasm (SPN). Due to the relative rarity of these tumors, pathologists are less familiar with the cytological features, especially on liquid-based cytology (LBC) which has been relatively recently introduced for endoscopic ultrasound-guided fine needle aspiration specimens.

Methods: We evaluated the detailed cytological features of 15 histologically confirmed ACC (7 conventional smears [CS], 8 LBC), and compared them with the LBC features of SPN (n = 9) and PanNEN (n = 9).

Results: Compared with CS, LBCs of ACC demonstrated significantly less bloody background. All ACCs demonstrated prominent nucleoli and macronucleoli on LBC. On comparison with the LBC features of SPN and PanNEN, most ACCs demonstrated a necrotic background with apoptotic debris while PanNEN and SPN did not show these features. Acinar structures were predominantly observed in ACC, while frequent pseudopapillary structures were seen only in SPN. Prominent nucleoli and macronucleoli were only seen in ACC.

Conclusions: ACC had characteristic cytological features that could be observed on LBC preparations, such as high cellularity, necrotic/apoptotic background, nuclear tangles, acinar arrangement of cells, and macronucleoli. These findings also help distinguish ACC from PanNEN and SPN on LBC. It is important to be familiar with these features, as an accurate diagnosis on endoscopic ultrasound-guided fine needle aspiration cytology would have impact on the management of the patient.

背景:胰腺腺细胞癌(ACC)是一种罕见的恶性上皮肿瘤,与胰腺神经内分泌肿瘤(PanNEN)和实性假乳头状肿瘤(SPN)等其他非胰腺导管性肿瘤有许多共同的细胞形态学特征。由于这些肿瘤相对罕见,病理学家对其细胞学特征不太熟悉,尤其是最近才在内镜超声引导下细针穿刺标本中引入的液基细胞学(LBC):我们评估了 15 例经组织学确诊的 ACC(7 例常规涂片 [CS]、8 例液基细胞学检查)的详细细胞学特征,并将其与 SPN(9 例)和 PanNEN(9 例)的液基细胞学检查特征进行了比较:结果:与CS相比,ACC的LBC血性背景明显减少。所有 ACC 的 LBC 均显示出突出的核小体和大核小体。与SPN和PanNEN的LBC特征相比,大多数ACC表现出坏死背景和凋亡碎片,而PanNEN和SPN则没有这些特征。在 ACC 中主要观察到针状结构,而只有在 SPN 中经常看到假乳头状结构。突出的核小体和大核小体仅见于 ACC:结论:ACC具有可在LBC制备物上观察到的特征性细胞学特征,如高细胞度、坏死/凋亡背景、核缠结、针状细胞排列和巨核细胞。这些发现也有助于在 LBC 上将 ACC 与 PanNEN 和 SPN 区分开来。熟悉这些特征非常重要,因为内镜超声引导下细针穿刺细胞学检查的准确诊断将对患者的治疗产生影响。
{"title":"Liquid-based cytology features of pancreatic acinar cell carcinoma: comparison with other non-ductal neoplasms of the pancreas.","authors":"Minji Kwon, Seung-Mo Hong, Kyoungbun Lee, Haeryoung Kim","doi":"10.4132/jptm.2024.06.25","DOIUrl":"10.4132/jptm.2024.06.25","url":null,"abstract":"<p><strong>Background: </strong>Acinar cell carcinoma (ACC) is a rare malignant epithelial neoplasm, which shares many cytomorphological features with other non-ductal pancreatic neoplasms such as pancreatic neuroendocrine neoplasm (PanNEN) and solid-pseudopapillary neoplasm (SPN). Due to the relative rarity of these tumors, pathologists are less familiar with the cytological features, especially on liquid-based cytology (LBC) which has been relatively recently introduced for endoscopic ultrasound-guided fine needle aspiration specimens.</p><p><strong>Methods: </strong>We evaluated the detailed cytological features of 15 histologically confirmed ACC (7 conventional smears [CS], 8 LBC), and compared them with the LBC features of SPN (n = 9) and PanNEN (n = 9).</p><p><strong>Results: </strong>Compared with CS, LBCs of ACC demonstrated significantly less bloody background. All ACCs demonstrated prominent nucleoli and macronucleoli on LBC. On comparison with the LBC features of SPN and PanNEN, most ACCs demonstrated a necrotic background with apoptotic debris while PanNEN and SPN did not show these features. Acinar structures were predominantly observed in ACC, while frequent pseudopapillary structures were seen only in SPN. Prominent nucleoli and macronucleoli were only seen in ACC.</p><p><strong>Conclusions: </strong>ACC had characteristic cytological features that could be observed on LBC preparations, such as high cellularity, necrotic/apoptotic background, nuclear tangles, acinar arrangement of cells, and macronucleoli. These findings also help distinguish ACC from PanNEN and SPN on LBC. It is important to be familiar with these features, as an accurate diagnosis on endoscopic ultrasound-guided fine needle aspiration cytology would have impact on the management of the patient.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"182-190"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent intestinal plasmablastic lymphoma and diffuse large B-cell lymphoma with a clonal relationship: a case report and literature review. 具有克隆关系的并发肠浆细胞淋巴瘤和弥漫大 B 细胞淋巴瘤:病例报告和文献综述。
IF 1.7 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-06-25 DOI: 10.4132/jptm.2024.05.14
Nao Imuta, Kosuke Miyai, Motohiro Tsuchiya, Mariko Saito, Takehiro Sone, Shinichi Kobayashi, Sho Ogata, Fumihiko Kimura, Susumu Matsukuma

Herein, we report a case of plasmablastic lymphoma (PBL) and diffuse large B-cell lymphoma (DLBCL) that occurred concurrently in the large intestine. An 84-year-old female presented with a palpable rectal tumor and ileocecal tumor observed on imaging analyses. Endoscopic biopsy of both lesions revealed lymphomatous round cells. Hartmann's operation and ileocecal resection were performed for regional control. The ileocecal lesion consisted of a proliferation of CD20/CD79a-positive lymphoid cells, indicative of DLBCL. In contrast, the rectal tumor showed proliferation of atypical cells with pleomorphic nuclei and abundant amphophilic cytoplasm, with immunohistochemical findings of CD38/CD79a/MUM1/MYC (+) and CD20/CD3/CD138/PAX5 (-). Tumor cells were positive for Epstein-Barr virus- encoded RNA based on in situ hybridization and MYC rearrangement in fluorescence in situ hybridization analysis. These findings indicated the rectal tumor was most likely a PBL. Sequencing analysis for immunoglobulin heavy variable genes indicated a common B-cell origin of the two sets of lymphoma cells. This case report and literature review provide new insights into PBL tumorigenesis.

在此,我们报告了一例同时发生在大肠的浆细胞淋巴瘤(PBL)和弥漫大 B 细胞淋巴瘤(DLBCL)病例。一名 84 岁的女性患者在影像学分析中发现可触及的直肠肿瘤和回盲部肿瘤。对这两个病灶进行的内镜活检发现了淋巴瘤圆形细胞。为了进行区域控制,患者接受了哈特曼手术和回盲部切除术。回盲部病变由 CD20/CD79a 阳性淋巴细胞增生组成,显示为 DLBCL。相比之下,直肠肿瘤表现为非典型细胞增生,细胞核多形,胞浆丰富,免疫组化结果为CD38/CD79a/MUM1/MYC(+)和CD20/CD3/CD138/PAX5(-)。根据原位杂交和荧光原位杂交分析,肿瘤细胞的Epstein-Barr病毒编码RNA和MYC重排均呈阳性。这些结果表明,直肠肿瘤很可能是一种 PBL。免疫球蛋白重型可变基因测序分析表明,两组淋巴瘤细胞来源于共同的 B 细胞。这篇病例报告和文献综述为我们提供了关于PBL肿瘤发生的新见解。
{"title":"Concurrent intestinal plasmablastic lymphoma and diffuse large B-cell lymphoma with a clonal relationship: a case report and literature review.","authors":"Nao Imuta, Kosuke Miyai, Motohiro Tsuchiya, Mariko Saito, Takehiro Sone, Shinichi Kobayashi, Sho Ogata, Fumihiko Kimura, Susumu Matsukuma","doi":"10.4132/jptm.2024.05.14","DOIUrl":"10.4132/jptm.2024.05.14","url":null,"abstract":"<p><p>Herein, we report a case of plasmablastic lymphoma (PBL) and diffuse large B-cell lymphoma (DLBCL) that occurred concurrently in the large intestine. An 84-year-old female presented with a palpable rectal tumor and ileocecal tumor observed on imaging analyses. Endoscopic biopsy of both lesions revealed lymphomatous round cells. Hartmann's operation and ileocecal resection were performed for regional control. The ileocecal lesion consisted of a proliferation of CD20/CD79a-positive lymphoid cells, indicative of DLBCL. In contrast, the rectal tumor showed proliferation of atypical cells with pleomorphic nuclei and abundant amphophilic cytoplasm, with immunohistochemical findings of CD38/CD79a/MUM1/MYC (+) and CD20/CD3/CD138/PAX5 (-). Tumor cells were positive for Epstein-Barr virus- encoded RNA based on in situ hybridization and MYC rearrangement in fluorescence in situ hybridization analysis. These findings indicated the rectal tumor was most likely a PBL. Sequencing analysis for immunoglobulin heavy variable genes indicated a common B-cell origin of the two sets of lymphoma cells. This case report and literature review provide new insights into PBL tumorigenesis.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"191-197"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam. 越南一家中心特发性炎症性肌病的免疫组化表达。
IF 1.7 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-06-25 DOI: 10.4132/jptm.2024.05.02
Dat Quoc Ngo, Si Tri Le, Khanh Hoang Phuong Phan, Thao Thi Phuong Doan, Linh Ngoc Khanh Nguyen, Minh Hoang Dang, Thien Thanh Ly, Thu Dang Anh Phan

Background: The identification of idiopathic inflammatory myopathies (IIMs) requires a comprehensive analysis involving clinical manifestations and histological findings. This study aims to provide insights into the histopathological and immunohistochemical aspects of IIMs.

Methods: This retrospective case series involved 56 patients diagnosed with IIMs at the Department of Pathology, University of Medicine and Pharmacy at Ho Chi Minh City, from 2019 to 2023. The histology and immunohistochemical expression of HLA-ABC, HLA-DR, C5b-9, Mx1/2/3, and p62 were detected.

Results: We examined six categories of inflammatory myopathy, including immunemediated necrotizing myopathy (58.9%), dermatomyositis (DM; 23.2%), overlap myositis (8.9%), antisynthetase syndrome (5.4%), inclusion body myositis (IBM; 1.8%), and polymyositis (1.8%). The average age of the patients was 49.7 ± 16.1 years, with a female-to-male ratio of 3:1. Inflammatory cell infiltration in the endomysium was present in 62.5% of cases, perifascicular atrophy was found in 17.8%, and fiber necrosis was observed in 42 cases (75.0%). Rimmed vacuoles were present in 100% of cases in the IBM group. Immunohistochemistry showed the following positivity rates: HLA-ABC (89.2%), HLA-DR (19.6%), C5b-9 (57.1%), and Mx1/2/3 (10.7%). Mx1/2/3 expression was high in DM cases. p62 vacuole deposits were noted in the IBM case. The combination of membrane attack complex and major histocompatibility complex I helped detect IIMs in 96% of cases.

Conclusions: The diagnosis of IIMs and their subtypes should be based on clinical features and histopathological characteristics. Immunohistochemistry plays a crucial role in the diagnosis and differentiation of these subgroups.

背景:鉴别特发性炎症性肌病(IIMs)需要对临床表现和组织学发现进行综合分析。本研究旨在深入了解特发性炎症性肌病的组织病理学和免疫组化方面:这项回顾性病例系列研究涉及胡志明市医药大学病理学系在 2019 年至 2023 年期间诊断出的 56 例 IIMs 患者。我们检测了组织学和免疫组化表达的 HLA-ABC、HLA-DR、C5b-9、Mx1/2/3 和 p62:我们检测了六类炎症性肌病,包括免疫介导坏死性肌病(58.9%)、皮肌炎(DM;23.2%)、重叠性肌炎(8.9%)、抗合成酶综合征(5.4%)、包涵体肌炎(IBM;1.8%)和多发性肌炎(1.8%)。患者的平均年龄为 49.7 ± 16.1 岁,男女比例为 3:1。62.5%的病例出现肌内膜炎性细胞浸润,17.8%的病例出现筋膜周围萎缩,42例(75.0%)病例出现纤维坏死。在 IBM 组中,100% 的病例都出现了边缘空泡。免疫组化显示了以下阳性率:HLA-ABC(89.2%)、HLA-DR(19.6%)、C5b-9(57.1%)和 Mx1/2/3(10.7%)。Mx1/2/3在DM病例中表达较高。膜攻击复合体和主要组织相容性复合体I的组合有助于在96%的病例中检测出IIMs:结论:IIMs 及其亚型的诊断应基于临床特征和组织病理学特征。免疫组化在这些亚型的诊断和鉴别中起着至关重要的作用。
{"title":"Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam.","authors":"Dat Quoc Ngo, Si Tri Le, Khanh Hoang Phuong Phan, Thao Thi Phuong Doan, Linh Ngoc Khanh Nguyen, Minh Hoang Dang, Thien Thanh Ly, Thu Dang Anh Phan","doi":"10.4132/jptm.2024.05.02","DOIUrl":"10.4132/jptm.2024.05.02","url":null,"abstract":"<p><strong>Background: </strong>The identification of idiopathic inflammatory myopathies (IIMs) requires a comprehensive analysis involving clinical manifestations and histological findings. This study aims to provide insights into the histopathological and immunohistochemical aspects of IIMs.</p><p><strong>Methods: </strong>This retrospective case series involved 56 patients diagnosed with IIMs at the Department of Pathology, University of Medicine and Pharmacy at Ho Chi Minh City, from 2019 to 2023. The histology and immunohistochemical expression of HLA-ABC, HLA-DR, C5b-9, Mx1/2/3, and p62 were detected.</p><p><strong>Results: </strong>We examined six categories of inflammatory myopathy, including immunemediated necrotizing myopathy (58.9%), dermatomyositis (DM; 23.2%), overlap myositis (8.9%), antisynthetase syndrome (5.4%), inclusion body myositis (IBM; 1.8%), and polymyositis (1.8%). The average age of the patients was 49.7 ± 16.1 years, with a female-to-male ratio of 3:1. Inflammatory cell infiltration in the endomysium was present in 62.5% of cases, perifascicular atrophy was found in 17.8%, and fiber necrosis was observed in 42 cases (75.0%). Rimmed vacuoles were present in 100% of cases in the IBM group. Immunohistochemistry showed the following positivity rates: HLA-ABC (89.2%), HLA-DR (19.6%), C5b-9 (57.1%), and Mx1/2/3 (10.7%). Mx1/2/3 expression was high in DM cases. p62 vacuole deposits were noted in the IBM case. The combination of membrane attack complex and major histocompatibility complex I helped detect IIMs in 96% of cases.</p><p><strong>Conclusions: </strong>The diagnosis of IIMs and their subtypes should be based on clinical features and histopathological characteristics. Immunohistochemistry plays a crucial role in the diagnosis and differentiation of these subgroups.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"174-181"},"PeriodicalIF":1.7,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting the utility of identifying nuclear grooves as unique nuclear changes by an object detector model. 通过物体检测器模型重新审视将核凹槽识别为独特核变化的实用性。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-05-01 Epub Date: 2024-04-30 DOI: 10.4132/jptm.2024.03.07
Pedro R F Rende, Joel Machado Pires, Kátia Sakimi Nakadaira, Sara Lopes, João Vale, Fabio Hecht, Fabyan E L Beltrão, Gabriel J R Machado, Edna T Kimura, Catarina Eloy, Helton E Ramos

Background: Among other structures, nuclear grooves are vastly found in papillary thyroid carcinoma (PTC). Considering that the application of artificial intelligence in thyroid cytology has potential for diagnostic routine, our goal was to develop a new supervised convolutional neural network capable of identifying nuclear grooves in Diff-Quik stained whole-slide images (WSI) obtained from thyroid fineneedle aspiration.

Methods: We selected 22 Diff-Quik stained cytological slides with cytological diagnosis of PTC and concordant histological diagnosis. Each of the slides was scanned, forming a WSI. Images that contained the region of interest were obtained, followed by pre-formatting, annotation of the nuclear grooves and data augmentation techniques. The final dataset was divided into training and validation groups in a 7:3 ratio.

Results: This is the first artificial intelligence model based on object detection applied to nuclear structures in thyroid cytopathology. A total of 7,255 images were obtained from 22 WSI, totaling 7,242 annotated nuclear grooves. The best model was obtained after it was submitted 15 times with the train dataset (14th epoch), with 67% true positives, 49.8% for sensitivity and 43.1% for predictive positive value.

Conclusions: The model was able to develop a structure predictor rule, indicating that the application of an artificial intelligence model based on object detection in the identification of nuclear grooves is feasible. Associated with a reduction in interobserver variability and in time per slide, this demonstrates that nuclear evaluation constitutes one of the possibilities for refining the diagnosis through computational models.

背景:核沟是甲状腺乳头状癌(PTC)的主要结构之一。考虑到人工智能在甲状腺细胞学中的应用具有常规诊断的潜力,我们的目标是开发一种新的有监督卷积神经网络,该网络能够在甲状腺细针穿刺术获得的 Diff-Quik 染色全切片图像(WSI)中识别核沟:我们选择了 22 张经 Diff-Quik 染色的细胞学切片,细胞学诊断为 PTC,组织学诊断一致。对每张切片进行扫描,形成 WSI。获取包含感兴趣区的图像,然后进行预格式化、核沟标注和数据增强技术。最终数据集按 7:3 的比例分为训练组和验证组:这是首个应用于甲状腺细胞病理学核结构的基于物体检测的人工智能模型。从 22 个 WSI 共获得 7255 张图像,共计 7242 个注释核沟。最佳模型是用训练数据集提交 15 次(第 14 个 epoch)后获得的,真阳性率为 67%,灵敏度为 49.8%,预测阳性值为 43.1%。结论该模型能够制定结构预测规则,表明基于物体检测的人工智能模型在核凹槽鉴定中的应用是可行的。该模型可减少观察者之间的差异和每张切片的时间,这表明核评价是通过计算模型完善诊断的可能性之一。
{"title":"Revisiting the utility of identifying nuclear grooves as unique nuclear changes by an object detector model.","authors":"Pedro R F Rende, Joel Machado Pires, Kátia Sakimi Nakadaira, Sara Lopes, João Vale, Fabio Hecht, Fabyan E L Beltrão, Gabriel J R Machado, Edna T Kimura, Catarina Eloy, Helton E Ramos","doi":"10.4132/jptm.2024.03.07","DOIUrl":"10.4132/jptm.2024.03.07","url":null,"abstract":"<p><strong>Background: </strong>Among other structures, nuclear grooves are vastly found in papillary thyroid carcinoma (PTC). Considering that the application of artificial intelligence in thyroid cytology has potential for diagnostic routine, our goal was to develop a new supervised convolutional neural network capable of identifying nuclear grooves in Diff-Quik stained whole-slide images (WSI) obtained from thyroid fineneedle aspiration.</p><p><strong>Methods: </strong>We selected 22 Diff-Quik stained cytological slides with cytological diagnosis of PTC and concordant histological diagnosis. Each of the slides was scanned, forming a WSI. Images that contained the region of interest were obtained, followed by pre-formatting, annotation of the nuclear grooves and data augmentation techniques. The final dataset was divided into training and validation groups in a 7:3 ratio.</p><p><strong>Results: </strong>This is the first artificial intelligence model based on object detection applied to nuclear structures in thyroid cytopathology. A total of 7,255 images were obtained from 22 WSI, totaling 7,242 annotated nuclear grooves. The best model was obtained after it was submitted 15 times with the train dataset (14th epoch), with 67% true positives, 49.8% for sensitivity and 43.1% for predictive positive value.</p><p><strong>Conclusions: </strong>The model was able to develop a structure predictor rule, indicating that the application of an artificial intelligence model based on object detection in the identification of nuclear grooves is feasible. Associated with a reduction in interobserver variability and in time per slide, this demonstrates that nuclear evaluation constitutes one of the possibilities for refining the diagnosis through computational models.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"117-126"},"PeriodicalIF":2.4,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11106606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's new in thyroid pathology 2024: updates from the new WHO classification and Bethesda system. 2024年甲状腺病理学的新进展:世界卫生组织新分类和贝塞斯达系统的更新。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-03-01 Epub Date: 2024-03-13 DOI: 10.4132/jptm.2024.03.06
Andrey Bychkov, Chan Kwon Jung

In line with the release of the 5th edition WHO Classification of Tumors of Endocrine Organs (2022) and the 3rd edition of the Bethesda System for Reporting Thyroid Cytopathology (2023), the field of thyroid pathology and cytopathology has witnessed key transformations. This digest brings to the fore the refined terminologies, newly introduced categories, and contentious methodological considerations pivotal to the updated classification.

随着第五版《世界卫生组织内分泌器官肿瘤分类》(2022 年)和第三版《贝塞斯达甲状腺细胞病理学报告系统》(2023 年)的发布,甲状腺病理学和细胞病理学领域发生了重大变革。本文摘将对更新分类中的术语、新引入的类别以及有争议的方法学考虑因素进行重点介绍。
{"title":"What's new in thyroid pathology 2024: updates from the new WHO classification and Bethesda system.","authors":"Andrey Bychkov, Chan Kwon Jung","doi":"10.4132/jptm.2024.03.06","DOIUrl":"10.4132/jptm.2024.03.06","url":null,"abstract":"<p><p>In line with the release of the 5th edition WHO Classification of Tumors of Endocrine Organs (2022) and the 3rd edition of the Bethesda System for Reporting Thyroid Cytopathology (2023), the field of thyroid pathology and cytopathology has witnessed key transformations. This digest brings to the fore the refined terminologies, newly introduced categories, and contentious methodological considerations pivotal to the updated classification.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"58 2","pages":"98-101"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer. 探索非小细胞肺癌免疫检查点抑制剂治疗反应的组织学预测生物标志物。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-03-01 Epub Date: 2024-02-26 DOI: 10.4132/jptm.2024.01.31
Uiju Cho, Soyoung Im, Hyung Soon Park

Treatment challenges persist in advanced lung cancer despite the development of therapies beyond the traditional platinum-based chemotherapy. The early 2000s marked a shift to tyrosine kinase inhibitors targeting epidermal growth factor receptor, ushering in personalized genetic-based treatment. A further significant advance was the development of immune checkpoint inhibitors (ICIs), especially for non-small cell lung cancer. These target programmed death-ligand 1 (PD-L1) and cytotoxic T lymphocyte antigen 4, which enhanced the immune response against tumor cells. However, not all patients respond, and immune-related toxicities arise. This review emphasizes identifying biomarkers for ICI response prediction. While PD-L1 is a widely used, validated biomarker, its predictive accuracy is imperfect. Investigating tumor-infiltrating lymphocytes, tertiary lymphoid structure, and emerging biomarkers such as high endothelial venule, Human leukocyte antigen class I, T-cell immunoreceptors with Ig and ITIM domains, and lymphocyte activation gene-3 counts is promising. Understanding and exploring additional predictive biomarkers for ICI response are crucial for enhancing patient stratification and overall care in lung cancer treatment.

尽管除了传统的铂类化疗外,晚期肺癌的治疗难题依然存在。本世纪初,以表皮生长因子受体为靶点的酪氨酸激酶抑制剂出现了转变,开创了基于基因的个性化治疗。另一个重大进展是免疫检查点抑制剂(ICIs)的开发,尤其是针对非小细胞肺癌的治疗。这些药物以程序性死亡配体 1(PD-L1)和细胞毒性 T 淋巴细胞抗原 4 为靶点,增强了针对肿瘤细胞的免疫反应。然而,并非所有患者都会产生反应,而且还会出现与免疫相关的毒性反应。本综述强调识别用于 ICI 反应预测的生物标志物。虽然 PD-L1 是一种广泛使用、经过验证的生物标志物,但其预测准确性并不完美。对肿瘤浸润淋巴细胞、三级淋巴结构以及高内皮静脉、人类白细胞抗原 I 类、具有 Ig 和 ITIM 结构域的 T 细胞免疫受体和淋巴细胞活化基因-3 计数等新兴生物标志物进行研究很有希望。了解和探索 ICI 反应的其他预测性生物标志物对于加强肺癌治疗中的患者分层和整体护理至关重要。
{"title":"Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non-small cell lung cancer.","authors":"Uiju Cho, Soyoung Im, Hyung Soon Park","doi":"10.4132/jptm.2024.01.31","DOIUrl":"10.4132/jptm.2024.01.31","url":null,"abstract":"<p><p>Treatment challenges persist in advanced lung cancer despite the development of therapies beyond the traditional platinum-based chemotherapy. The early 2000s marked a shift to tyrosine kinase inhibitors targeting epidermal growth factor receptor, ushering in personalized genetic-based treatment. A further significant advance was the development of immune checkpoint inhibitors (ICIs), especially for non-small cell lung cancer. These target programmed death-ligand 1 (PD-L1) and cytotoxic T lymphocyte antigen 4, which enhanced the immune response against tumor cells. However, not all patients respond, and immune-related toxicities arise. This review emphasizes identifying biomarkers for ICI response prediction. While PD-L1 is a widely used, validated biomarker, its predictive accuracy is imperfect. Investigating tumor-infiltrating lymphocytes, tertiary lymphoid structure, and emerging biomarkers such as high endothelial venule, Human leukocyte antigen class I, T-cell immunoreceptors with Ig and ITIM domains, and lymphocyte activation gene-3 counts is promising. Understanding and exploring additional predictive biomarkers for ICI response are crucial for enhancing patient stratification and overall care in lung cancer treatment.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"49-58"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare goblet cell adenocarcinoma arising from Barrett's esophagus: the first reported case in the esophagus. 由巴雷特食管引发的罕见鹅口疮细胞腺癌:食管中的首个报告病例。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-03-01 Epub Date: 2024-01-08 DOI: 10.4132/jptm.2023.12.26
Chi Eun Oh, Sung Eun Kim, Sun-Ju Oh

Goblet cell adenocarcinoma (GCA) is a rare and distinctive amphicrine tumor comprised of goblet-like mucinous cells and neuroendocrine cells. It is believed to originate from pluripotent stem cells located at the base of crypts. GCA predominantly arises from the appendix, with a few reported cases in extra-appendiceal locations such as the colorectum, small intestine, and stomach. In this case report, we present a unique instance of a 64-year-old male who initially received a diagnosis of neuroendocrine carcinoma in the distal esophagus based on biopsy but, following resection, was subsequently re-diagnosed with GCA arising from Barrett's esophagus.

鹅口疮细胞腺癌(GCA)是一种罕见而独特的两性肿瘤,由鹅口疮样粘液细胞和神经内分泌细胞组成。据信,它起源于位于隐窝底部的多能干细胞。GCA 主要发生在阑尾,也有少数病例发生在阑尾以外的部位,如结肠直肠、小肠和胃。在本病例报告中,我们介绍了一个独特的病例:一名 64 岁的男性最初根据活检结果被诊断为食管远端神经内分泌癌,但在切除食管后,他又被再次诊断为来自巴雷特食管的 GCA。
{"title":"A rare goblet cell adenocarcinoma arising from Barrett's esophagus: the first reported case in the esophagus.","authors":"Chi Eun Oh, Sung Eun Kim, Sun-Ju Oh","doi":"10.4132/jptm.2023.12.26","DOIUrl":"10.4132/jptm.2023.12.26","url":null,"abstract":"<p><p>Goblet cell adenocarcinoma (GCA) is a rare and distinctive amphicrine tumor comprised of goblet-like mucinous cells and neuroendocrine cells. It is believed to originate from pluripotent stem cells located at the base of crypts. GCA predominantly arises from the appendix, with a few reported cases in extra-appendiceal locations such as the colorectum, small intestine, and stomach. In this case report, we present a unique instance of a 64-year-old male who initially received a diagnosis of neuroendocrine carcinoma in the distal esophagus based on biopsy but, following resection, was subsequently re-diagnosed with GCA arising from Barrett's esophagus.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"81-86"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139098938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases. 非黑素细胞皮肤肿瘤中 TRPS1 的表达:对 200 例病例的免疫组化分析。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-03-01 Epub Date: 2024-02-26 DOI: 10.4132/jptm.2024.01.23
Yi A Liu, Phyu P Aung, Yunyi Wang, Jing Ning, Priyadharsini Nagarajan, Jonathan L Curry, Carlos A Torres-Cabala, Doina Ivan, Victor G Prieto, Qingqing Ding, Woo Cheal Cho

Background: Although trichorhinophalangeal syndrome type 1 (TRPS1) was initially thought to be highly sensitive and specific for carcinomas and mesenchymal tumors of mammary origin, more recent data suggest its expression is not limited to breast neoplasms but also can be seen in other cutaneous neoplasms, such as extramammary Paget disease and squamous cell carcinoma (SCC) in situ.

Methods: Two-hundred cases of non-melanocytic cutaneous neoplasm, including basal cell carcinomas (BCCs) (n = 41), SCCs (n = 35), Merkel cell carcinomas (MCCs) (n = 25), and adnexal neoplasms (n = 99), were tested for TRPS1 expression using a monoclonal anti- TRPS1 rabbit anti-human antibody.

Results: TRPS1 expression was present in almost all cases of SCC (94%), with a median H-score of 200, while it was either absent or only focally present in most BCCs (90%), with a median H-score of 5. The difference between BCCs and SCCs in H-score was significant (p < .001). All MCCs (100%) lacked TRPS1 expression. TRPS1 expression was frequently seen in most adnexal neoplasms, benign and malignant, in variable intensity and proportion but was consistently absent in apocrine carcinomas. All endocrine mucin-producing sweat gland carcinomas (EMPSGCs) (100%, 6/6) showed diffuse and strong TRPS1 immunoreactivity, with a median H-score of 300, which was significantly different (p < .001) than that of BCCs.

Conclusions: Our study shows that TRPS1 may be an effective discriminatory marker for BCCs and SCCs. It also has a role in distinguishing BCCs from EMPSGCs.

背景:尽管毛细血管畸形综合征 1 型(TRPS1)最初被认为对乳腺来源的癌和间质瘤具有高度敏感性和特异性,但最近的数据表明,它的表达不仅限于乳腺肿瘤,也可见于其他皮肤肿瘤,如乳腺外 Paget 病和原位鳞状细胞癌(SCC):方法:使用单克隆抗 TRPS1 兔抗人抗体检测 200 例非黑色素细胞皮肤肿瘤(包括基底细胞癌(BCC)(n = 41)、SCC(n = 35)、梅克尔细胞癌(MCC)(n = 25)和附件肿瘤(n = 99))的 TRPS1 表达:结果:几乎所有SCC病例(94%)都存在TRPS1表达,H评分中位数为200,而大多数BCC病例(90%)要么没有TRPS1表达,要么只是局部存在,H评分中位数为5。BCC 和 SCC 的 H 评分差异显著(p < .001)。所有 MCC(100%)都没有 TRPS1 表达。大多数附件肿瘤(良性和恶性)中都常有TRPS1表达,表达强度和比例不一,但在内分泌癌中始终缺乏TRPS1表达。所有分泌内分泌粘液的汗腺癌(EMPSGCs)(6/6,100%)均表现出弥漫和强烈的TRPS1免疫反应,H-score中位数为300,与BCCs相比有显著差异(p < .001):我们的研究表明,TRPS1可能是BCC和SCC的有效鉴别标志物。结论:我们的研究表明,TRPS1 可能是 BCC 和 SCC 的有效鉴别标志物,在区分 BCC 和 EMPSGCs 方面也有一定作用。
{"title":"TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases.","authors":"Yi A Liu, Phyu P Aung, Yunyi Wang, Jing Ning, Priyadharsini Nagarajan, Jonathan L Curry, Carlos A Torres-Cabala, Doina Ivan, Victor G Prieto, Qingqing Ding, Woo Cheal Cho","doi":"10.4132/jptm.2024.01.23","DOIUrl":"10.4132/jptm.2024.01.23","url":null,"abstract":"<p><strong>Background: </strong>Although trichorhinophalangeal syndrome type 1 (TRPS1) was initially thought to be highly sensitive and specific for carcinomas and mesenchymal tumors of mammary origin, more recent data suggest its expression is not limited to breast neoplasms but also can be seen in other cutaneous neoplasms, such as extramammary Paget disease and squamous cell carcinoma (SCC) in situ.</p><p><strong>Methods: </strong>Two-hundred cases of non-melanocytic cutaneous neoplasm, including basal cell carcinomas (BCCs) (n = 41), SCCs (n = 35), Merkel cell carcinomas (MCCs) (n = 25), and adnexal neoplasms (n = 99), were tested for TRPS1 expression using a monoclonal anti- TRPS1 rabbit anti-human antibody.</p><p><strong>Results: </strong>TRPS1 expression was present in almost all cases of SCC (94%), with a median H-score of 200, while it was either absent or only focally present in most BCCs (90%), with a median H-score of 5. The difference between BCCs and SCCs in H-score was significant (p < .001). All MCCs (100%) lacked TRPS1 expression. TRPS1 expression was frequently seen in most adnexal neoplasms, benign and malignant, in variable intensity and proportion but was consistently absent in apocrine carcinomas. All endocrine mucin-producing sweat gland carcinomas (EMPSGCs) (100%, 6/6) showed diffuse and strong TRPS1 immunoreactivity, with a median H-score of 300, which was significantly different (p < .001) than that of BCCs.</p><p><strong>Conclusions: </strong>Our study shows that TRPS1 may be an effective discriminatory marker for BCCs and SCCs. It also has a role in distinguishing BCCs from EMPSGCs.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"72-80"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified. TBX21、CXCR3、GATA3、CCR4 和 TCF1 在结节性滤泡辅助 T 细胞淋巴瘤和非特异性外周 T 细胞淋巴瘤中的免疫组化表达对临床病理的影响。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-03-01 Epub Date: 2024-01-22 DOI: 10.4132/jptm.2024.01.04
Bogyeong Han, Sojung Lim, Jeemin Yim, Young Keun Song, Jiwon Koh, Sehui Kim, Cheol Lee, Young A Kim, Yoon Kyung Jeon

Background: The classification of nodal peripheral T-cell lymphoma (PTCL) has evolved according to histology, cell-of-origin, and genetic alterations. However, the comprehensive expression pattern of follicular helper T-cell (Tfh) markers, T-cell factor-1 (TCF1), and Th1- and Th2-like molecules in nodal PTCL is unclear.

Methods: Eighty-two cases of nodal PTCL were classified into 53 angioimmunoblastic T-cell lymphomas (AITLs)/nodal T-follicular helper cell lymphoma (nTFHL)-AI, 18 PTCLs-Tfh/nTFHL-not otherwise specified (NOS), and 11 PTCLs-NOS according to the revised 4th/5th World Health Organization classifications. Immunohistochemistry for TCF1, TBX21, CXCR3, GATA3, and CCR4 was performed.

Results: TCF1 was highly expressed in up to 68% of patients with nTFHL but also in 44% of patients with PTCL-NOS (p > .05). CXCR3 expression was higher in AITLs than in non-AITLs (p = .035), whereas GATA3 expression was higher in non-AITL than in AITL (p = .007) and in PTCL-Tfh compared to AITL (p = .010). Of the cases, 70% of AITL, 44% of PTCLTfh/ nTFHL-NOS, and 36% of PTCL-NOS were subclassified as the TBX21 subtype; and 15% of AITL, 38% of PTCL-Tfh/nTFHL-NOS, and 36% of PTCL-NOS were subclassified as the GATA3 subtype. The others were an unclassified subtype. CCR4 expression was associated with poor progression-free survival (PFS) in patients with PTCL-Tfh (p < .001) and nTFHL (p = .023). The GATA3 subtype showed poor overall survival in PTCL-NOS compared to TBX21 (p = .046) and tended to be associated with poor PFS in patients with non-AITL (p = .054).

Conclusions: The TBX21 subtype was more prevalent than the GATA3 subtype in AITL. The GATA3 subtype was associated with poor prognosis in patients with non-AITL and PTCL-NOS.

背景:结节性外周T细胞淋巴瘤(PTCL)的分类是根据组织学、原发细胞和基因改变演变而来的。然而,结节性 PTCL 中滤泡辅助 T 细胞(Tfh)标记物、T 细胞因子-1(TCF1)以及 Th1 和 Th2 类分子的综合表达模式尚不清楚:根据世界卫生组织修订的第4/5版分类法,82例结节性PTCL被分为53例血管免疫母细胞T细胞淋巴瘤(AITLs)/结节性T滤泡辅助细胞淋巴瘤(nTFHL)-AI、18例PTCLs-Tfh/nTFHL-未另作规定(NOS)和11例PTCLs-NOS。对TCF1、TBX21、CXCR3、GATA3和CCR4进行了免疫组化:结果:TCF1在高达68%的nTFHL患者和44%的PTCL-NOS患者中高表达(P > .05)。CXCR3在AITL中的表达高于非AITL(p = .035),而GATA3在非AITL中的表达高于AITL(p = .007),在PTCL-Tfh中的表达高于AITL(p = .010)。在这些病例中,70%的AITL、44%的PTCLTfh/ nTFHL-NOS和36%的PTCL-NOS亚分类为TBX21亚型;15%的AITL、38%的PTCL-Tfh/ nTFHL-NOS和36%的PTCL-NOS亚分类为GATA3亚型。其他则为未分类亚型。CCR4的表达与PTCL-Tfh(p < .001)和nTFHL(p = .023)患者的无进展生存期(PFS)差有关。与TBX21相比,GATA3亚型在PTCL-NOS中的总生存率较低(p = .046),在非AITL患者中往往与较差的PFS相关(p = .054):结论:在AITL中,TBX21亚型比GATA3亚型更常见。结论:在AITL患者中,TBX21亚型比GATA3亚型更普遍,而在非AITL和PTCL-NOS患者中,GATA3亚型与预后不良有关。
{"title":"Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.","authors":"Bogyeong Han, Sojung Lim, Jeemin Yim, Young Keun Song, Jiwon Koh, Sehui Kim, Cheol Lee, Young A Kim, Yoon Kyung Jeon","doi":"10.4132/jptm.2024.01.04","DOIUrl":"10.4132/jptm.2024.01.04","url":null,"abstract":"<p><strong>Background: </strong>The classification of nodal peripheral T-cell lymphoma (PTCL) has evolved according to histology, cell-of-origin, and genetic alterations. However, the comprehensive expression pattern of follicular helper T-cell (Tfh) markers, T-cell factor-1 (TCF1), and Th1- and Th2-like molecules in nodal PTCL is unclear.</p><p><strong>Methods: </strong>Eighty-two cases of nodal PTCL were classified into 53 angioimmunoblastic T-cell lymphomas (AITLs)/nodal T-follicular helper cell lymphoma (nTFHL)-AI, 18 PTCLs-Tfh/nTFHL-not otherwise specified (NOS), and 11 PTCLs-NOS according to the revised 4th/5th World Health Organization classifications. Immunohistochemistry for TCF1, TBX21, CXCR3, GATA3, and CCR4 was performed.</p><p><strong>Results: </strong>TCF1 was highly expressed in up to 68% of patients with nTFHL but also in 44% of patients with PTCL-NOS (p > .05). CXCR3 expression was higher in AITLs than in non-AITLs (p = .035), whereas GATA3 expression was higher in non-AITL than in AITL (p = .007) and in PTCL-Tfh compared to AITL (p = .010). Of the cases, 70% of AITL, 44% of PTCLTfh/ nTFHL-NOS, and 36% of PTCL-NOS were subclassified as the TBX21 subtype; and 15% of AITL, 38% of PTCL-Tfh/nTFHL-NOS, and 36% of PTCL-NOS were subclassified as the GATA3 subtype. The others were an unclassified subtype. CCR4 expression was associated with poor progression-free survival (PFS) in patients with PTCL-Tfh (p < .001) and nTFHL (p = .023). The GATA3 subtype showed poor overall survival in PTCL-NOS compared to TBX21 (p = .046) and tended to be associated with poor PFS in patients with non-AITL (p = .054).</p><p><strong>Conclusions: </strong>The TBX21 subtype was more prevalent than the GATA3 subtype in AITL. The GATA3 subtype was associated with poor prognosis in patients with non-AITL and PTCL-NOS.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":" ","pages":"59-71"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malignant potential of neuroendocrine microtumor of the pancreas harboring high-grade transformation: lesson learned from a patient with von Hippel-Lindau syndrome. 胰腺神经内分泌微肿瘤高级别转化的恶性潜能:从一名冯-希佩尔-林道综合征患者身上汲取的教训。
IF 2.4 Q3 PATHOLOGY Pub Date : 2024-03-01 Epub Date: 2024-03-13 DOI: 10.4132/jptm.2024.02.13
Jongwon Lee, Kyung Jin Lee, Dae Wook Hwang, Seung-Mo Hong

Pancreatic neuroendocrine microtumor (PNEMT) is a neuroendocrine tumor (NET) < 0.5 cm in diameter, and it is considered benign. We report a PNEMT with high-grade transformation (HGT). A man in his 60s with von Hippel-Lindau syndrome underwent surgical resection of a NET. A second sub-centimeter nodule with a nodule-in-nodule pattern was discovered. The 0.4 cm outer nodule contained clear columnar cells with round nuclei and indistinct nucleoli, while the 0.1 cm inner nodule had eosinophilic cells with an increased nuclear to cytoplasmic ratio, vesicular nuclei, and prominent nucleoli. Tumor cells in the outer and inner nodules were synaptophysin and chromogranin positive. Only the inner nodule was p53 positive, while the outer nodule was exclusively positive for carbonic anhydrase 9 and vimentin. The Ki-67 labeling indices for the outer and inner nodules were 2.1% (grade 1) and 44.3% (grade 3), respectively. This nodule was determined to be a PNEMT with HGT. Our findings suggest that a PNEMT may not always be benign and can undergo HGT.

胰腺神经内分泌微瘤(PNEMT)是一种直径小于 0.5 厘米的神经内分泌肿瘤(NET),被认为是良性的。我们报告了一例伴有高级别转化(HGT)的 PNEMT。一名 60 多岁、患有 von Hippel-Lindau 综合征的男子接受了 NET 手术切除。手术中发现了第二个亚厘米结节,其形态为结节内结节。0.4 厘米的外侧结节含有透明的柱状细胞,核圆形,核小体模糊不清;0.1 厘米的内侧结节含有嗜酸性细胞,核与细胞质比率增高,核呈泡状,核小体突出。外结节和内结节的肿瘤细胞突触素和嗜铬粒蛋白均呈阳性。只有内结节的 p53 呈阳性,而外结节的碳酸酐酶 9 和波形蛋白完全呈阳性。外部和内部结节的 Ki-67 标记指数分别为 2.1%(1 级)和 44.3%(3 级)。该结节被确定为伴有 HGT 的 PNEMT。我们的研究结果表明,PNEMT不一定都是良性的,也可能发生 HGT。
{"title":"Malignant potential of neuroendocrine microtumor of the pancreas harboring high-grade transformation: lesson learned from a patient with von Hippel-Lindau syndrome.","authors":"Jongwon Lee, Kyung Jin Lee, Dae Wook Hwang, Seung-Mo Hong","doi":"10.4132/jptm.2024.02.13","DOIUrl":"10.4132/jptm.2024.02.13","url":null,"abstract":"<p><p>Pancreatic neuroendocrine microtumor (PNEMT) is a neuroendocrine tumor (NET) < 0.5 cm in diameter, and it is considered benign. We report a PNEMT with high-grade transformation (HGT). A man in his 60s with von Hippel-Lindau syndrome underwent surgical resection of a NET. A second sub-centimeter nodule with a nodule-in-nodule pattern was discovered. The 0.4 cm outer nodule contained clear columnar cells with round nuclei and indistinct nucleoli, while the 0.1 cm inner nodule had eosinophilic cells with an increased nuclear to cytoplasmic ratio, vesicular nuclei, and prominent nucleoli. Tumor cells in the outer and inner nodules were synaptophysin and chromogranin positive. Only the inner nodule was p53 positive, while the outer nodule was exclusively positive for carbonic anhydrase 9 and vimentin. The Ki-67 labeling indices for the outer and inner nodules were 2.1% (grade 1) and 44.3% (grade 3), respectively. This nodule was determined to be a PNEMT with HGT. Our findings suggest that a PNEMT may not always be benign and can undergo HGT.</p>","PeriodicalId":46933,"journal":{"name":"Journal of Pathology and Translational Medicine","volume":"58 2","pages":"91-97"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10948253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pathology and Translational Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1